The global liquid biopsy market is estimated to reach $1,173.5m in 2019. The kits & reagents submarket holds the biggest share of the global liquid biopsy market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 180-page report you will receive 179 charts– all unavailable elsewhere.
The 180-page report provides clear detailed insight into the liquid biopsy market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Liquid Biopsy Market forecast to 2029
• Revenue forecasts for the Liquid Biopsy Market Forecast by Product to 2029: • Instruments • Kits & Reagents • Services
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Sample to 2029: • Blood • Urine • Other Samples
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Biomarker to 2029: • Circulating Tumor Cells (CTC) • Circulating Tumor DNA (CtDNA) • Exosomes • Other Biomarkers
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Cancer to 2029: • Breast Cancer • Colorectal Cancer • Liver Cancer • Lung Cancer • Prostate Cancer • Other Cancers
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by End-User to 2029: • Hospitals • Diagnostic Laboratories • Academic Institutions • Cancer Research Centres
Each submarket is further segmented by regional market.
• Revenue forecasts for the Liquid Biopsy Market Forecast by Region to 2029:
North America: • U.S. • Canada • Mexico
Europe: • Germany • UK • France • Italy • Spain • Russia • Rest of Europe
Asia-Pacific: • Japan • China • India • Australia • South Korea • Rest of Asia-Pacific
LAMEA: • Brazil • Turkey • Venezuela • Saudi Arabia • Republic of South Africa • Rest of LAMEA
• Profiles of the selected leading companies: • Abbott • Beckman Coulter • Biocept, Inc. • Bio-Rad Laboratories • Biotime • Caris Lifesciences • F. Hoffman-La Roche • Guardant Health, Inc. • Illumina, Inc. • MDxHealth SA • Menarini Silicon Biosystems, Inc. • Myriad Genetics, Inc. • OPKO Health, Inc. • Qiagen N.V. • Sysmex Inostics • Trovagene, Inc.
• This report discusses Drivers, Restraints, Opportunities and Threats of the global liquid biopsy market
• The report also includes a PESTLE Analysis of the Global Liquid Biopsy Market
• Key questions answered by this report: • How is the Liquid Biopsy market evolving? • What are the drivers and restraints for the growth of the liquid biopsy market? • What are the market shares of each segment of the overall liquid biopsy market in 2018? • How will each liquid biopsy submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029? • How will the market shares for each liquid biopsy submarket develop to 2029? • Which individual therapies will prevail and how will these shifts be responded to? • What will be the main driver for the overall market to 2029? • How will political and regulatory factors influence the regional markets and submarkets? • How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029? • Who are the leading players and what are their prospects over the forecast period? • How will the industry evolve during the period between 2019 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Liquid Biopsy Market. You find data, trends and predictions.
Buy our report today Liquid Biopsy Market Forecast : Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Liquid Biopsy Market Overview
1.2 Liquid Biopsy Market Definition & Scope
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Key Questions Answered by This Analytical Report
1.6 How This Report Delivers
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Liquid Biopsy Market Overview
2.1 History of Liquid Biopsies
2.2 Advantages of Liquid Biopsies
2.3 Trends in Liquid Biopsy Market
2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits
2.3.2 Emergence of Oncogenic Mutations Detection Platforms
2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures
2.4 Market Dynamics
2.4.1 Drivers
2.4.1.1 Rising incidence of cancer globally
2.4.1.2 Increasing Rate of Aging Population
2.4.1.3 Rising demand for safe and minimally invasive procedures
2.4.1.4 Advantages of liquid biopsy
2.4.2 Restraints
2.4.2.1 Disparity in reimbursements
2.4.2.2 Strict regulatory environment
2.4.3 Opportunities:
2.4.3.1 Increasing involvement of global market players through collaborations/agreements
2.4.3.2 Progress in the development of liquid biopsy tests
2.5 Global Liquid Biopsy Market: Revenue Forecast, 2018-2029
2.6 Regulatory Landscape for Liquid Biopsies
2.7 Latest developments in the liquid biopsy industry
2.7.1 Emergence of artificial intelligence technologies is set to boost the liquid biopsy market
2.7.2 Liquid biopsy is considered to be one of the most significant breakthrough treatments for cancer
2.7.3 Multi-Target Liquid Biopsy would be a novel clinical test to watch out in 2019
3. Global Liquid Biopsy Market by Product Type: Market Forecast to 2029
3.1 Global Liquid Biopsy Market, By Product Type, Revenue Forecast, 2018-2029
3.2 Instruments Segment
3.2.1 Global Liquid Biopsy Market, Instruments Segment Revenue Forecast, 2018-2029
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
